• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Royalty Pharma plc - Class A Ordinary Shares (NQ:RPRX)

    45.44 +0.04 (+0.09%)
    Streaming Delayed Price Updated: 1:41 PM EST, Feb 25, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,295,683
    Open 45.13
    Bid (Size) 45.44 (200)
    Ask (Size) 45.45 (100)
    Prev. Close 45.40
    Today's Range 45.01 - 45.62
    52wk Range 29.66 - 46.14
    Shares Outstanding 388,132,400
    Dividend Yield 1.94%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    3 Healthcare Stocks Walking a Fine Line
    From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry have been rewarded lately as healthcare... 
    Via StockStory
    Topics Stocks
    News headline image
    5 Insightful Analyst Questions From Royalty Pharma’s Q4 Earnings Call
    Royalty Pharma’s fourth quarter results did not meet Wall Street’s revenue or earnings expectations, with management attributing the performance to a combination of gradual product transitions in key... 
    Via StockStory
    Topics Earnings

    Performance

    YTD
    +16.9%
    +16.9%
    1 Month
    +12.3%
    +12.3%
    3 Month
    +14.9%
    +14.9%
    6 Month
    +26.3%
    +26.3%
    1 Year
    +34.4%
    +34.4%

    More News

    Read More
    News headline image
    Patient Capital Bet Heavily on Chime Financial (CHYM) With a 2.04 Million Share Purchase ↗
    Via The Motley Fool
    Royalty Pharma PLC-CL A (NASDAQ:RPRX) Shares Dip Despite Strong Portfolio Growth and 2026 Guidance Beat ↗
    Via Chartmill
    Why Is TEVA Stock Rising Pre-Market Today? ↗
    Via Stocktwits
    News headline image
    Royalty Pharma (RPRX) Q4 2025 Earnings Transcript ↗
    Via The Motley Fool
    Topics Bonds
    News headline image
    Royalty Pharma (NASDAQ:RPRX) Reports Sales Below Analyst Estimates In Q4 CY2025 Earnings
    Via StockStory
    News headline image
    Royalty Pharma Reports Q4 and Full Year 2025 Results
    From Royalty Pharma plc
    Via GlobeNewswire
    News headline image
    What To Expect From Royalty Pharma’s (RPRX) Q4 Earnings
    Via StockStory
    Topics World Trade
    News headline image
    3 Mid-Cap Stocks We Keep Off Our Radar
    Via StockStory
    News headline image
    3 Profitable Stocks with Open Questions
    Via StockStory
    News headline image
    Royalty Pharma to Announce Fourth Quarter and Full Year 2025 Financial Results on February 11, 2026
    From Royalty Pharma plc
    Via GlobeNewswire
    News headline image
    Royalty Pharma to Highlight Accomplishments and Provide Business Update at 44th Annual J.P. Morgan Healthcare Conference
    From Royalty Pharma plc
    Via GlobeNewswire
    News headline image
    Royalty Pharma and Teva Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo
    From Royalty Pharma plc
    Via GlobeNewswire
    News headline image
    Teva and Royalty Pharma Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo
    From Teva Pharmaceutical Industries Ltd
    Via GlobeNewswire
    News headline image
    Royalty Pharma Announces Dividend Increase
    From Royalty Pharma plc
    Via GlobeNewswire
    News headline image
    Branded Pharmaceuticals Stocks Q3 Results: Benchmarking Royalty Pharma (NASDAQ:RPRX)
    Via StockStory
    Topics Artificial Intelligence Intellectual Property
    News headline image
    3 Overrated Stocks We Steer Clear Of
    Via StockStory
    News headline image
    Royalty Pharma Acquires Remaining Royalty Interest in Roche’s Evrysdi for $240 Million and Potential Milestones
    From Royalty Pharma plc
    Via GlobeNewswire
    News headline image
    3 Healthcare Stocks We’re Skeptical Of
    Via StockStory
    Topics Stocks
    News headline image
    Royalty Pharma Acquires Royalty Interest in Nuvalent’s Neladalkib and Zidesamtinib for Up to $315 Million
    From Royalty Pharma plc
    Via GlobeNewswire
    News headline image
    What's going on in today's after hours session ↗
    Via Chartmill
    News headline image
    Royalty Pharma PLC-CL A (NASDAQ:RPRX) Shows Strong Technical Setup for a Breakout ↗
    Via Chartmill
    News headline image
    Royalty Pharma and Denali Therapeutics Announce $275 Million Royalty Funding Agreement
    From Royalty Pharma plc
    Via GlobeNewswire
    News headline image
    Denali Therapeutics and Royalty Pharma Announce $275 Million Royalty Funding Agreement
    From Denali Therapeutics Inc.
    Via GlobeNewswire

    Frequently Asked Questions

    Is Royalty Pharma plc - Class A Ordinary Shares publicly traded?
    Yes, Royalty Pharma plc - Class A Ordinary Shares is publicly traded.
    What exchange does Royalty Pharma plc - Class A Ordinary Shares trade on?
    Royalty Pharma plc - Class A Ordinary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for Royalty Pharma plc - Class A Ordinary Shares?
    The ticker symbol for Royalty Pharma plc - Class A Ordinary Shares is RPRX on the Nasdaq Stock Market
    What is the current price of Royalty Pharma plc - Class A Ordinary Shares?
    The current price of Royalty Pharma plc - Class A Ordinary Shares is 45.44
    When was Royalty Pharma plc - Class A Ordinary Shares last traded?
    The last trade of Royalty Pharma plc - Class A Ordinary Shares was at 02/25/26 01:41 PM ET
    What is the market capitalization of Royalty Pharma plc - Class A Ordinary Shares?
    The market capitalization of Royalty Pharma plc - Class A Ordinary Shares is 17.64B
    How many shares of Royalty Pharma plc - Class A Ordinary Shares are outstanding?
    Royalty Pharma plc - Class A Ordinary Shares has 18B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.